Mortality and Thromboembolic Events in Hypercoagulable States from Rotational Thromboelastography (ROTEM) in Patients Who Undergo Coronary Bypass Surgery
Purpose:This study is to identify the prevalence of preoperative hypercoagulability
in Thailand high-risk population assessed by Rotational thromboelastography (ROTEM) and
test hypothesis that the pre-surgical ROTEM statuses are related to MACCE
at 1, 12, 60 months after coronary bypass graft surgery (CABG). Method:This is a prospective
cohort in consecutive patients who underwent on-pump CABG between 2013-2015.
Blood samplings were collected and analyzed using ROTEM preoperatively. Hypercoagulable
state was defined as any clotting time (CT) orclot formation time (CFT)
below the lower normal limit or amplitude 10 min after CT (A10), Maximum clot
firmness(MCF)in ROTEM measurement is above the upper normal limit of EXTEM, INTEM and
FIBTEM.Results:43% of CABG patients who
were diagnosed as hypercoagulability state assessed by ROTEM. Mortality rate was
slightly higher in hypercoagulable patients without statistical significance
(9% vs 5.1%; P = 0.461). However, overall combined uneventful rate was significantly increased in
hypercoagulable patients in 5 years follow-up (27.2% vs 8.6%; P = 0.012). In
univariate analysis, ROTEM hypercoagulability is associated major
References
[1]
Gozdzik, W., Adamik, B., Wysoczanski, G., Gozdzik, A., Rachwalik, M., Skalec, T., et al. (2017) Preoperative Thromboelastometry for the Prediction of Increased Chest Tube Output in Cardiac Surgery: A Retrospective Study. Medicine (Baltimore), 96, e7669. https://doi.org/10.1097/MD.0000000000007669
[2]
Gurbel, P.A., Bliden, K.P., Guyer, K., Cho, P.W., Zaman, K.A., Kreutz, R.P., et al. (2005) Platelet Reactivity in Patients and Recurrent Events Post-Stenting: Results of the Prepare Post-Stenting Study. Journal of the American College of Cardiology, 46, 1820-1826. https://doi.org/10.1016/j.jacc.2005.07.041
[3]
Kim, E., Shim, H.S., Kim, W.H., Lee, S.Y., Park, S.K., Yang, J.H., et al. (2016) Predictive Value of Intraoperative Thromboelastometry for the Risk of Perioperative Excessive Blood Loss in Infants and Children Undergoing Congenital Cardiac Surgery: A Retrospective Analysis. Journal of Cardiothoracic and Vascular Anesthesia, 30, 1172-1178. https://doi.org/10.1053/j.jvca.2016.03.132
[4]
McCrath, D.J., Cerboni, E., Frumento, R.J., Hirsh, A.L. and Bennett-Guerrero, E. (2005) Thromboelastography Maximum Amplitude Predicts Postoperative Thrombotic Complications Including Myocardial Infarction. Anesthesia & Analgesia, 100, 1576-1583. https://doi.org/10.1213/01.ANE.0000155290.86795.12
[5]
Soh, S., Kwak, Y.L., Song, J.W., Yoo, K.J., Kim, H.J. and Shim, J.K. (2017) Rotational Thromboelastometry Predicts Increased Bleeding after Off-Pump Coronary Bypass Surgery. The Annals of Thoracic Surgery, 104, 1318-1324.
https://doi.org/10.1016/j.athoracsur.2017.02.046
[6]
Wikkelso, A., Wetterslev, J., Moller, A.M. and Afshari, A. (2017) Thromboelastography (TEG) or Rotational Thromboelastometry (ROTEM) to Monitor Haemostatic Treatment in Bleeding Patients: A Systematic Review with Meta-Analysis and Trial Sequential Analysis. Anaesthesia, 72, 519-531.
https://doi.org/10.1111/anae.13765
[7]
Zaky, A. (2017) Thromboelastometry versus Rotational Thromboelastography in Cardiac Surgery. Seminars in Cardiothoracic and Vascular Anesthesia, 21, 206-211.
https://doi.org/10.1177/1089253217697146
[8]
Bochsen, L., Nielsen, A.B., Steinbruchel, D.A. and Johansson, P.I. (2007) Higher Thrombelastograph Platelet Reactivity in Cardiac Surgery Patients than in Blood Donors. Scandinavian Cardiovascular Journal, 41, 321-324.
https://doi.org/10.1080/14017430701225923
[9]
Dai, Y., Lee, A., Critchley, L.A. and White, P.F. (2009) Does Thromboelastography Predict Postoperative Thromboembolic Events? A Systematic Review of the Literature. Anesthesia & Analgesia, 108, 734-742.
https://doi.org/10.1213/ane.0b013e31818f8907
[10]
Kashuk, J.L., Moore, E.E., Sabel, A., Barnett, C., Haenel, J., Le, T., et al. (2009) Rapid Thrombelastography (r-TEG) Identifies Hypercoagulability and Predicts Thromboembolic Events in Surgical Patients. Surgery, 146, 764-772.
https://doi.org/10.1016/j.surg.2009.06.054
[11]
Zacho, M., Rafiq, S., Kelbaek, H., Johansson, P.I., Nielsen, M.B., Steinbruchel, D.A., et al. (2013) Hypercoagulability in Relation to Coronary Artery Bypass Graft Patency and Clinical Outcome. Scandinavian Cardiovascular Journal, 47, 104-108.
https://doi.org/10.3109/14017431.2012.754934
[12]
Chen, A. and Teruya, J. (2009) Global Hemostasis Testing Thromboelastography: Old Technology, New Applications. Clinics in Laboratory Medicine, 29, 391-407.
https://doi.org/10.1016/j.cll.2009.04.003
[13]
Pekelharing, J., Furck, A., Banya, W., Macrae, D. and Davidson, S.J. (2014) Comparison between Thromboelastography and Conventional Coagulation Tests after Cardiopulmonary Bypass Surgery in the Paediatric Intensive Care Unit. International Journal of Laboratory Hematology, 36, 465-471.
https://doi.org/10.1111/ijlh.12171
[14]
Lang, T. and von Depka, M. (2006) Possibilities and Limitations of Thrombelastometry/-Graphy. Hamostaseologie, 26, S20-S29.
https://doi.org/10.1055/s-0037-1617078
[15]
Tannock, L. (2000) Dyslipidemia in Chronic Kidney Disease. In: Feingold, K.R., Anawalt, B., Boyce, A., Chrousos, G., Dungan, K., Grossman, A., et al., Eds., Endotext, MDText.com Inc., South Dartmouth, 3.
[16]
Rac-Albu, M., Iliuta, L., Guberna, S.M. and Sinescu, C. (2014) The Role of Ankle-Brachial Index for Predicting Peripheral Arterial Disease. Maedica (Buchar), 9, 295-302.
[17]
Rafiq, S., Johansson, P.I., Ostrowski, S.R., Stissing, T. and Steinbruchel, D.A. (2012) Hypercoagulability in Patients Undergoing Coronary Artery Bypass Grafting: Prevalence, Patient Characteristics and Postoperative Outcome. European Journal of Cardio-Thoracic Surgery, 41, 550-555. https://doi.org/10.1093/ejcts/ezr001
[18]
Tantry, U.S., Bliden, K.P., Suarez, T.A., Kreutz, R.P., Dichiara, J. and Gurbel, P.A. (2010) Hypercoagulability, Platelet Function, Inflammation and Coronary Artery Disease Acuity: Results of the Thrombotic Risk Progression (TRIP) Study. Platelets, 21, 360-367. https://doi.org/10.3109/09537100903548903
[19]
Roeloffzen, W.W., Kluin-Nelemans, H.C., Mulder, A.B., Veeger, N.J., Bosman, L. and de Wolf, J.T. (2010) In Normal Controls, Both Age and Gender Affect Coagulability as Measured by Thrombelastography. Anesthesia & Analgesia, 110, 987-994.
https://doi.org/10.1213/ANE.0b013e3181d31e91
[20]
Schreiber, M.A., Differding, J., Thorborg, P., Mayberry, J.C. and Mullins, R.J. (2005) Hypercoagulability Is Most Prevalent Early after Injury and in Female Patients. The Journal of Trauma, 58, 475-480.
https://doi.org/10.1097/01.TA.0000153938.77777.26
[21]
Theusinger, O.M., Nurnberg, J., Asmis, L.M., Seifert, B. and Spahn, D.R. (2010) Rotation Thromboelastometry (ROTEM) Stability and Reproducibility over Time. European Journal of Cardio-Thoracic Surgery, 37, 677-683.
https://doi.org/10.1016/j.ejcts.2009.07.038
[22]
Kon, Z.N., Kwon, M.H., Collins, M.J., Kallam, S., Sangrampurkar, R., Ozeki, T., et al. (2006) Off-Pump Coronary Artery Bypass Leads to a Regional Hypercoagulable State Not Detectable Using Systemic Markers. Innovations (Phila), 1, 232-238.
https://doi.org/10.1097/01.imi.0000242160.21278.b7
[23]
Manchio, J.V., Gu, J., Romar, L., Brown, J., Gammie, J., Pierson, R.N., et al. (2005) Disruption of Graft Endothelium Correlates with Early Failure after Off-Pump Coronary Artery Bypass Surgery. The Annals of Thoracic Surgery, 79, 1991-1998.
https://doi.org/10.1016/j.athoracsur.2004.12.054
[24]
Rafiq, S., Johansson, P.I., Zacho, M., Stissing, T., Kofoed, K., Lilleor, N.B., et al. (2012) Thrombelastographic Haemostatic Status and Antiplatelet Therapy after Coronary Artery Bypass Surgery: TEG-CABG Trial, Assessing and Monitoring the Antithrombotic Effect of Clopidogrel and Aspirin versus Aspirin Alone in Hypercoagulable Patients: Study Protocol for a Randomized Controlled Trial. Trials, 13, 48. https://doi.org/10.1186/1745-6215-13-48
[25]
Huynh, T., Theroux, P., Bogaty, P., Nasmith, J. and Solymoss, S. (2001) Aspirin, Warfarin, or the Combination for Secondary Prevention of Coronary Events in Patients with Acute Coronary Syndromes and Prior Coronary Artery Bypass Surgery. Circulation, 103, 3069-3074. https://doi.org/10.1161/01.CIR.103.25.3069
[26]
Kulik, A., Ruel, M., Jneid, H., Ferguson, T.B., Hiratzka, L.F., Ikonomidis, J.S., et al. (2015) Secondary Prevention after Coronary Artery Bypass Graft Surgery: A Scientific Statement from the American Heart Association. Circulation, 131, 927-964.
https://doi.org/10.1161/CIR.0000000000000182
[27]
Henderson, W.G., Goldman, S., Copeland, J.G., Moritz, T.E. and Harker, L.A. (1989) Antiplatelet or Anticoagulant Therapy after Coronary Artery Bypass Surgery. A Meta-Analysis of Clinical Trials. Annals of Internal Medicine, 111, 743-750.
https://doi.org/10.7326/0003-4819-111-9-743
[28]
Taggart, D.P., Boyle, R., de Belder, M.A. and Fox, K.A. (2011) The 2010 ESC/EACTS Guidelines on Myocardial Revascularisation. Heart, 97, 445-446.
https://doi.org/10.1136/hrt.2010.216135
